Reducing calories rejuvenates muscles, Pfizer's new drug wins approval, minors advance lawsuit against Facebook

Today ChatGPT read 1030 top news stories. After removing previously covered events, there are 3 articles with a significance score over 7.

[7.1] Reducing calorie intake improves muscle health and activates important pathways. — National Institutes of Health (.gov)

A study conducted by the National Institutes of Health suggests that reducing overall calorie intake can rejuvenate muscles and activate biological pathways important for good health. The study analyzed data from participants in the Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy (CALERIE) study and found that even a modest reduction of 12% in daily caloric intake was enough to activate most of the biological pathways associated with healthy aging. The researchers also found that calorie restriction upregulated genes responsible for energy generation and metabolism while downregulating inflammatory genes, leading to lower inflammation.

[7.0] Pfizer's new drug Velsipity gains U.S. approval for ulcerative colitis treatment. — Reuters

Pfizer has received U.S. approval for a new drug called Velsipity to treat ulcerative colitis, a painful gut condition that affects over a million people in the U.S. The drug has shown promise in reducing symptoms and is priced at $6,164 for a month's supply, which is in line with other treatments. Unlike some other medications for this condition, Velsipity doesn't require an initial lab test, making it potentially easier for patients to start treatment.

[7.0] Minors suing Facebook for social media addiction win important ruling. — Bloomberg ($)

A California state judge has allowed minors and parents to advance their lawsuits against Meta Inc.'s Facebook and other tech companies, focusing on the claim that these firms were negligent in designing their platforms in a way that could harm minors. The ruling bypasses Section 230 of the Communications Decency Act, which usually shields internet companies from liability, stating that it doesn't prevent the negligence claim from proceeding as the design features of the platforms — rather than the specific content — are causing the harms.

Want to read more?

See additional news on newsminimalist.com.

Thanks for reading us and see you tomorrow,

Vadim